Journal attitudes and outcomes of preprints in dermatology

Abstract

Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299:65-7. 2 Kim YH, Tavallaee M, Sundram U et al. Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and S ezary syndrome with variable CD30 expression level: a multi-institution collaborative project. J Clin Oncol 2015; 33:3750-8. 3 Mah evas T, Ram-Wolff C, Battistella M et al. Dramatic response to brentuximab vedotin in a refractory nontransformed CD30mycosis fungoides allowing allogeneic stem cell transplantation and longterm complete remission.

Dermatology Articles in Preprint Servers: A Cross-sectional Study

“…An analysis of 61 dermatology articles in medRxiv found only 51% (31/61) of articles were subsequently published. 2 The low rate of publication may be due to the quality of preprints that do not meet criteria to be published following peer review.…”

The Evolution of Dermatology Articles From Preprint to Publication: A Comparative Analysis

“…To the editor: Preprints refer to scientific manuscript versions before publication in peer-reviewed journals, with preprint servers allowing for rapid research dissemination. 1,2 Over half of dermatology preprints are published in journals, 3 yet few studies explored differences between preprints and publications. Therefore, our objectives were to investigate changes between dermatology preprints and published versions.…”